Multiplikator Forward P/S: Aethlon Medical, Inc. (AEMD)
Aethlon Medical (AEMD) is striving to optimize its global filter distribution networks to maintain high margins. The forward price-to-sales ratio on the GURU.Markets chart demonstrates progress toward this goal, with the metric holding at 9.60. However, geopolitical sanctions and the clinical trial stage of the Hemopurifier for oncology treatment create certain obstacles to rapid business scaling.
Ringkesan rincian data analitis Aethlon Medical Corp (AEMD)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Aethlon Medical|AEMD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Aethlon Medical|AEMD - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Aethlon Medical Corp|AEMD - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Aethlon Medical|Rasio cepet aethlonmedical.com
- rincian asil keuangan lan kelipatan valuasi:
AEMD - Penghasilan resik perusahaan|Bathi sing dikarepake Aethlon Medical|AEMD - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Aethlon|AEMD - Pangali PEG|Pangali EV/EBITDA Aethlon Medical Corp|AEMD - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Aethlon Medical|AEMD - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan aethlonmedical.com|AEMD - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Aethlon Medical
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:AEMD (Aethlon Medical, Inc.)
To build a defensive portfolio, fundamental screening requires an analysis of the market capitalization to expected revenue ratio, which allows for the valuation of future cash flows. Since Aethlon Medical (AEMD) is in the clinical testing stage without pricing power, the forward price-to-sales ratio reflects the market's speculative expectations regarding the commercial success of the equipment.
Karo sapa Aethlon Medical saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|INBS: Multiplikator Forward P/S|Beyond Air (XAIR) - Multiplikator Forward P/S|PFSA (Profusa) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep STRATA Skin SSKN|Multiplikator forward rega marang pendapatan GCTK (GlucoTrack)|Rasio rega marang pendapatan sing dikarepake NAOV|Multiplikator Forward P/S VERO (Venus Concept Inc.)|Rega forward marang dodolan NUWE|ASXC - Rasio rega marang prakiraan pendapatan|AVGR: Rasio rega marang prakiraan pendapatan|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cutera Inc (CUTR)|Rasio rega marang prakiraan pendapatan Know Labs, Inc.|Kapitalisasi marang prakiraan pendapatan NARI (inarimedical.com)|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
